REGN earnings & options Regeneron Pharmaceuticals, Inc.
Implied vs actual, past reports
Definitions →Solid bars: the actual two-session reaction around each report (signed value printed below). Amber outlines: the move options priced beforehand — recorded from August 2026 onward, so older reports show the actual only.
Report-by-report record
| Report date | EPS act / est | Revenue act / est | Reaction | Implied | IV30 before → after |
|---|---|---|---|---|---|
| Jul 30, 2026 | 14.29 / 10.16 | 4.29B / 3.82B | +9.7% | not recorded | — |
| Apr 29, 2026 | 9.47 / 8.91 | 3.61B / 3.48B | -3.4% | not recorded | — |
| Jan 30, 2026 | 11.44 / 10.74 | 3.88B / 3.81B | +0.7% | not recorded | — |
| Oct 28, 2025 | 11.83 / 9.65 | 3.75B / 3.59B | +11.5% | not recorded | — |
| Aug 01, 2025 | 12.89 / 8.43 | 3.68B / 3.29B | +4.8% | not recorded | — |
| Apr 29, 2025 | 8.22 / 8.62 | 3.03B / 3.25B | -2.0% | not recorded | — |
| Feb 04, 2025 | 12.07 / 11.21 | 3.79B / 3.74B | +7.5% | not recorded | — |
| Oct 31, 2024 | 12.46 / 11.69 | 3.72B / 3.67B | -8.6% | not recorded | — |
| Aug 01, 2024 | 11.56 / 10.61 | 3.55B / 3.38B | +0.3% | not recorded | — |
| May 02, 2024 | 9.55 / 10.17 | 3.15B / 3.23B | +5.9% | not recorded | — |
| Feb 02, 2024 | 11.86 / 10.73 | 3.43B / 3.29B | -2.2% | not recorded | — |
| Nov 02, 2023 | 11.59 / 10.72 | 3.36B / 3.22B | +3.2% | not recorded | — |
| Aug 03, 2023 | 10.24 / 9.84 | 3.16B / 3.02B | +4.7% | not recorded | — |
| May 04, 2023 | 10.09 / 9.25 | 3.16B / 3.00B | -5.1% | not recorded | — |
| Feb 03, 2023 | 12.56 / 10.03 | 3.41B / 3.12B | +3.9% | not recorded | — |
| Nov 03, 2022 | 11.14 / 9.48 | 2.94B / 2.92B | -0.0% | not recorded | — |
Reaction = close before the report date to the close of the session after it (report timing is not published by the source; this two-session window contains the reaction either way). Implied moves are recorded live before each report from August 2026 onward — never reconstructed. Earnings data: Financial Modeling Prep.